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Improving formaldehyde consumption drives
methanol assimilation in engineered E. coli
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Due to volatile sugar prices, the food vs fuel debate, and recent increases in the supply of
natural gas, methanol has emerged as a promising feedstock for the bio-based economy.
However, attempts to engineer Escherichia coli to metabolize methanol have achieved limited
success. Here, we provide a rigorous systematic analysis of several potential pathway bot-
tlenecks. We show that regeneration of ribulose 5-phosphate in E. coli is insufﬁcient to
sustain methanol assimilation, and overcome this by activating the sedoheptulose bispho-
sphatase variant of the ribulose monophosphate pathway. By leveraging the kinetic isotope
effect associated with deuterated methanol as a chemical probe, we further demonstrate that
under these conditions overall pathway ﬂux is kinetically limited by methanol dehydrogenase.
Finally, we identify NADH as a potent kinetic inhibitor of this enzyme. These results provide
direction for future engineering strategies to improve methanol utilization, and underscore
the value of chemical biology methodologies in metabolic engineering.
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A principle motivation for industrial biomanufacturing isthe desire to replace fossil fuel-based processes with moresustainable ones utilizing renewable feedstocks1. While
most efforts to date have relied on easily accessible sugars from
corn or sugarcane, these substrates compete with food supply. In
the quest for alternative feedstocks, methanol has emerged as a
promising candidate2. Its current price is comparable to that of
glucose, despite being more energy-dense, with a 50% greater
degree of reduction per C-mole. Furthermore, methanol can be
produced renewably from municipal solid waste and biogas
through syngas as an intermediate3, or by using renewable elec-
tricity through electrocatalytic reduction of CO24. Conversion of
methane to methanol as a starting material for value-added
processes has also been proposed as a way to monetize stranded
natural gas, a large fraction of which is currently ﬂared in the
absence of an economically viable alternative5,6. For these rea-
sons, the concept of a methanol economy has received con-
siderable attention7.
The use of methanol in bioprocessing presents several chal-
lenges. Chief among these is that there has been only limited
success in engineering methylotrophs to produce high levels of
heterologous products2,8–10. Metabolic engineering in methylo-
trophs is relatively slow, and the genetic tools are not as well
developed as for model organisms. For example, targeted gene
deletions in Bacillus methanolicus, a methylotroph of commercial
interest for its native production of amino acids, have not been
reported to date. Because of this, signiﬁcant interest has arisen in
importing methanol assimilation into the more tractable host,
Escherichia coli. This concept, dubbed synthetic methylotrophy11,
aims to combine the advantages of methanol as an attractive
carbon substrate for fermentation with the robust engineering
tools and range of downstream heterologous products available in
E. coli.
Several groups have attempted to develop a methylotrophic
E. coli. In the seminal paper, Müller and co-workers demon-
strated the ability of E. coli cells expressing a heterologous operon
containing methanol dehydrogenase (Mdh) and the ribulose
monophosphate (RuMP) pathway enzymes hexulose phosphate
synthase (Hps) and phosphohexulose isomerase (Phi) to incor-
porate 13C methanol into central carbon metabolites12. Recently,
Whitaker and co-workers showed that supplementation of
methanol during growth on yeast extract could allow a similarly
engineered strain to reach higher cell densities than with yeast
extract alone, and could produce the heterologous product nar-
ingenin with a signiﬁcant amount of the carbon derived from
methanol13. Follow-up work found threonine to be the primary
beneﬁcial component of yeast extract14, and re-routing glucose
ﬂux through the oxidative pentose phosphate pathway (PPP) by
knocking out pgi further improved methanol assimilation15. To
date, however, no group has been able to demonstrate growth of
E. coli on methanol as a sole carbon source. Similar efforts in
Corynebacterium glutamicum have met with the same results16.
Various hypotheses of potential bottlenecks to methanol
assimilation have been put forth. Chief among these are the
relatively poor kinetics of heterologously expressed Mdh and the
thermodynamically challenging oxidation of methanol to for-
maldehyde with NAD as electron acceptor. Low activity of the
enzyme limits total methanol ﬂux, and the high thermodynamic
barrier requires both a high intracellular NAD:NADH ratio and
rapid consumption of formaldehyde through the ribulose
monophosphate (RuMP) cycle, to keep reaction far from equili-
brium and driven in the forward direction. This has led to efforts
to ﬁnd and engineer more active variants of Mdh17, and a strategy
involving the co-localization of Mdh and Hps, the ﬁrst enzyme of
the RuMP pathway, to prevent the build-up of formaldehyde18.
However, the effects of these modiﬁcations on the incorporation
of methanol into central metabolism have not been characterized.
More broadly, there has been no systematic attempt to quanti-
tatively assess the potential bottlenecks of methanol assimilation.
Such an analysis is a critical component of developing a rational
strategy to improve methanol assimilation, because it justiﬁes the
considerable time and resource expenditure associated with
developing a solution to the proposed bottleneck.
To address this need, in this work we engineer strains with
similar performance to the previously reported strains, and
develop quantitative assays to systematically assess pathway
limitations to identify the most promising targets for further
metabolic engineering. Our analysis reveals the depletion of
ribulose 5-phosphate (Ru5P), the co-substrate of Hps, as the
primary limitation to high methanol ﬂux in carbon-starved cells,
as this leads to the build-up of formaldehyde and the dissipation
of the driving force. By inhibiting glycolytic ﬂux with iodoacetate
and overexpressing E. coli glpX, we activate the sedoheptulose
bisphosphatase (SBPase) variant of the RuMP pathway, which
reduces the steady-state formaldehyde concentration by a factor
of three, and increases the incorporation of 13CH3OH by a factor
of two. Thermodynamic calculations and experiments using the
kinetic isotope effect associated with deuterated methanol show
that, under these conditions, methanol oxidation is forward dri-
ven and limited by the kinetics of Mdh. These results represent a
signiﬁcant step toward establishing synthetic methylotrophy, and
provide speciﬁc direction for subsequent work to develop a
methylotrophic E. coli.
Results
Formaldehyde assimilation is limited in carbon-starved cells.
The engineered pathway of methanol assimilation is shown in
Fig. 1. Overcoming the uphill thermodynamics of NAD-
dependent methanol oxidation (ΔG0′=+34.2 kJ mol−1)
requires a low concentration of the product formaldehyde
(CH2O) to maintain the driving force. With a [CH3OH] of 250
mM and a typical E. coli NAD:NADH ratio of 31.319, the reaction
is predicted to reach equilibrium at a [CH2O] of just 50 μM
(Supplementary Fig. 1, Supplementary Note 1, and Supplemen-
tary Table 1). Rapid formaldehyde assimilation by the down-
stream pathway enzymes is therefore necessary for maintaining
forward-driven methanol assimilation.
To examine the ability of E. coli cells engineered for methanol
metabolism to metabolize formaldehyde, we used the assay
procedure developed by Müller et al.12 to measure [CH2O] in
carbon-starved cells treated with 250 mM methanol. Starved cells
were chosen in light of the eventual goal of developing a strain
that can grow solely on methanol, which requires that this strain
must be able to initiate and sustain methanol consumption in the
absence of any other carbon substrate. Cells expressing the
evolved Mdh from C. necator17 (plasmid pETmdh) produced 56
± 4 μM formaldehyde, with an initial rate of 7.2 ± 0.2 μMmin−1
OD−1 (intervals represent s.d., n= 3, Fig. 2), which is similar to
those achieved previously12,13. Surprisingly, cells additionally
expressing Hps from B. methanolicus and Phi fromMethylococcus
capsulatus (plasmid pETMEOH500) produced only slightly less
formaldehyde (Fig. 2b), despite the superior kinetics of these
enzymes compared to Mdh (Supplementary Table 2). We
hypothesized that availability of Ru5P, the co-substrate of Hps,
might limit formaldehyde assimilation, and performed the assay
again while supplementing 6 g L−1 xylose, which is metabolized
through the pentose phosphate pathway (PPP, Fig. 2a), to
increase the [Ru5P]. This resulted in a dramatically reduced
steady-state [CH2O] of 7.5 ± 2.6 μM or 4.7 ± 1.7-fold compared to
the Mdh control (Fig. 2b). To conﬁrm that the reduction in
[CH2O] was due to increased availability of Ru5P, we measured
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the intracellular [Ru5P] in cells with and without xylose
supplementation, and found an 8.2 ± 1.7-fold increase in the
presence of added xylose (Fig. 2c). Additionally, repeating the
experiment with glycerol as supplemental carbon source resulted
in a much less signiﬁcant reduction in [CH2O], indicating the
effect was not simply due to a general response of starved cells to
a growth substrate (Supplementary Fig. 2).
Interestingly, cells expressing only Mdh produced less
formaldehyde when supplemented with xylose than the unsup-
plemented control, and at a slower initial rate (Fig. 2b). The lower
steady state is likely due to the 3.2 ± 1.0-fold increased [NADH]
in xylose-metabolizing cells compared to starved cells (Supple-
mentary Fig. 3a), which again highlights the thermodynamic
challenge associated with the reaction. The lower initial velocity
suggested that NADH could be a kinetic inhibitor of the forward
direction. This was veriﬁed by in vitro assay with puriﬁed Mdh,
which showed ~50% reduction in activity in the presence
of typical cellular levels of NADH (Supplementary Fig. 3b).
These observations suggest that to further improve methanol
oxidation rates, strategies should be developed to reduce the
cellular [NADH], or engineer or evolve an NADH-insensitive
variant of Mdh.
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Fig. 2 Insufﬁcient Ru5P concentration in carbon-starved cells limits formaldehyde assimilation. a Detailed enzymatic reactions and metabolic pathways
involved in methanol metabolism, showing the entry points of glycogen (the primary carbon source during starvation) through glycolysis, and xylose
through the pentose phosphate pathway (PPP). Heterologous reactions unique to methanol assimilation are shown in blue. Glycolysis reactions are shown
in purple, and PPP reactions in green. Dotted and dashed green lines added for clarity. b Formaldehyde levels over time after addition of 250mM methanol
to starved cells of E. coli MG1655(DE3) ΔfrmA with either no additional substrate (blue) or 6 g L−1 xylose (orange). Solid lines represent cells expressing
only Mdh, and dashed lines denote cells expressing the full methanol assimilation pathway (Mdh, Hps, and Phi). c Relative ribulose 5-phosphate (Ru5P)
concentration in cells with no substrate or xylose. Error bars represent s.d. of n= 3 biological replicates (three individual colonies). H6P: D-arabino-3-
hexulo-6-phosphate, F6P: fructose 6-phosphate, G6P: glucose 6-phosphate, FBP: fructose 1,6-bisphosphate, DHAP: dihydroxyacetone phosphate, G3P:
glyceraldehyde 3-phosphate, PEP: phosphoenolpyruvate, E4P: erythrose 4-phosphate, S7P: sedoheptulose 7-phosphate, R5P: ribose 5-phosphate, Ru5P:
ribulose 5-phosphate, Xu5P: xylulose 5-phosphate
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Fig. 1 The pathway of methanol assimilation in E. coli. Heterologous enzymes required for methanol assimilation in E. coli are shown in blue. Methanol
dehydrogenase (Mdh) catalyzes the thermodynamically uphill NAD-dependent oxidation of methanol to formaldehyde (ΔG0′=+34.2 kJ mol−1), which is
ligated to ribulose 5-phosphate (Ru5P) in an aldol reaction catalyzed by hexulose phosphate synthase (Hps). The resulting hexulose (H6P) is isomerized
by phosphohexulose isomerase (Phi) to fructose 6-phosphate (F6P), which is metabolized through native E. coli central metabolism. A portion of the F6P
must be used to regenerate Ru5P through the ribulose monophosphate (RuMP) cycle to enable further formaldehyde assimilation. Two major variants of
this cycle are known, the transaldolase (Tal) and sedoheptulose bisphosphatase (SBPase), which are named for the enzyme that produces sedoheptulose
7-phosphate, and differ in their ATP requirements. The red moiety denotes the position of assimilated methanol. H6P: D-arabino-3-hexulo-6-phosphate,
G3P: glyceraldehyde 3-phosphate
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The SBPase pathway improves formaldehyde assimilation.
Given the ultimate goal of using methanol as the sole carbon
source for E. coli, we sought to improve the regeneration of Ru5P
without the need for xylose supplementation. A genome-scale
model of E. coli simulating hypothetical growth on methanol
revealed a threefold decrease in proportional ﬂux through gly-
ceraldehyde 3-phosphate dehydrogenase (GAPDH) relative to the
same ﬂux for growth on glucose (Supplementary Fig. 4). This
reaction connects the RuMP pathway to lower glycolysis (Fig. 3a),
thus we reasoned that by inhibiting this reaction, we could
maintain larger pool sizes of upper glycolytic and RuMP pathway
intermediates in starved cells. To test this possibility experi-
mentally, we repeated the assay in cells treated with 1 mM
iodoacetate (IA), a potent inhibitor of GAPDH20. Inhibition was
veriﬁed by analyzing metabolite pools by LC-MS/MS (Fig. 3b).
Metabolites downstream of GAPDH, e.g., phosphoenolpyruvate
(PEP) and 3-phosphoglycerate (3PG) became almost undetect-
able, whereas the concentrations of the metabolites directly
upstream of GAPDH—G3P and DHAP—rose by a factor of 14 ±
2. Fructose bisphosphate (FBP), which is present in very low
concentration in starved cells21, increased in concentration by a
factor of 39 ± 24. IA had no functional effect on the activity of
Mdh, or on Hps and Phi, as evidenced by formaldehyde assay
controls with cells expressing just Mdh, or with xylose supple-
mentation (Fig. 3c). Despite the increases in [G3P] and [FBP],
increases in [F6P] and [Ru5P] were comparatively small (Fig. 3b).
Consequently, there was little improvement in [CH2O] in cells
expressing the full pathway ([CH2O]= 46 ± 3 μM), compared to
cells expressing only Mdh ([CH2O]= 49 ± 2 μM) (Fig. 3c).
Entry into the transaldolase variant of the RuMP pathway in E.
coli is mediated by the transaldolase and transketolase reactions
(Fig. 4a), both of which require F6P as a substrate. Thus, in the
absence of a large increase in [F6P], the lack of substantial
increase in [Ru5P] upon IA treatment is not surprising. We
therefore asked if we could convert the large increase in [FBP]
upon IA treatment into an increase in [F6P]. F6P is converted to
FBP by phosphofructokinase in an essentially irreversible reaction
that uses ATP (Fig. 4b). We hypothesized that by expressing a
gluconeogenic FBPase, which catalyzes the dephosphorylation of
FBP to F6P with water, we could enable reverse carbon ﬂow from
FBP to upper glycolysis, and from there into the RuMP pathway.
E. coli has a major (Type I) and minor (Type II) FBPase, encoded
by fbp and glpX, respectively. The major FBPase is inhibited by
AMP22. Since [AMP] is increased in starved cells21, we chose to
overexpress the AMP-insensitive variant encoded by glpX23 on a
compatible plasmid (pACglpX), and repeat the formaldehyde
assays.
Overexpression of glpX in combination with IA treatment
resulted in a dramatic 6.4 ± 2.1-fold increase in [F6P], and a
corresponding 4.0 ± 1.2-fold increase in [Ru5P] (Fig. 4c). Gratify-
ingly, this was accompanied by a 3.0 ± 0.3-fold decrease in steady-
state [CH2O] in cells expressing the full pathway ([CH2O]= 17 ±
1.5 μM), compared to Mdh-only ([CH2O]= 52 ± 1 μM) (Fig. 4d).
Both IA and glpX overexpression were required to achieve this
effect. To verify the reduction in [CH2O] was due to increased
assimilation into central metabolism, the experiment was
repeated with 13CH3OH, and the isotopic enrichment of various
glycolytic intermediates measured. Labeling of the representative
molecule F6P was approximately double in the IA+ glpX
treatment compared to the IA-only control treatment (Fig. 4e),
with a mean isotopic enrichment of 27.5 ± 2.2% compared to
15.2 ± 0.5%, reﬂecting an increase in the rate of formaldehyde
assimilation due to glpX overexpression. The increased labeling
also conﬁrms that Ru5P is not regenerated through the oxidative
PPP, since this pathway results in the loss of labeled carbon.
Further labeling experiments in a Δzwf strain conﬁrmed that
there is little oxidative PPP ﬂux under these conditions
(Supplementary Fig. 5).
Some Type II FBPases are known to have promiscuous activity
as sedoheptulose bisphosphatases (SBPases), including the
enzyme encoded by plasmid-borne glpX in B. methanolicus24. If
the E. coli variant was similarly promiscuous, conversion of SBP
to S7P in the glpX-overexpressing strain would provide an
alternative explanation for the improved formaldehyde assimila-
tion (Fig. 5a). To test this possibility, we puriﬁed the E. coli GlpX,
and assayed the conversion of SBP to S7P using LC-MS/MS in a
coupled assay with puriﬁed fructose bisphosphate aldolase
(FbaA), which promiscuously catalyzes the conversion of DHAP
and E4P to the commercially unavailable SBP. In contrast to
previous literature23, we found that E. coli GlpX catalyzed the
quantitative conversion of E4P and DHAP to S7P in the presence
of FbaA (Fig. 5b), demonstrating this enzyme has SBPase activity,
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and suggesting the possibility of carbon ﬂux through the SBPase
variant of the RuMP pathway. In this variant of the pathway, S7P
is formed from through the dephosphorylation of SBP, which is
in turn formed from erythrose 4-phosphate (E4P) and DHAP
through FbaA (Fig. 5a, orange lines). This pathway requires an
additional ATP compared to the transaldolase (TAL) pathway25,
in which S7P is formed from F6P and GAP (Fig. 5a, gray dotted
lines). Analysis of metabolite pool sizes showed that, upon
addition of IA, the [SBP] increased by 5.6 ± 2.0-fold. Over-
expression of glpX reduced this to untreated levels, providing
evidence of in vivo conversion of SBP to S7P (Fig. 5c). In
addition, the [S7P] increased dramatically upon overexpression of
glpX, regardless of whether cells were treated with IA or not (8.3
± 1.8-fold and 15 ± 3-fold, respectively, Fig. 5c).
In principle, increased [S7P] could be due to SBPase activity, or
to the originally hypothesized increased entry into the RuMP
pathway through transaldolase mediated by a higher [F6P]. To
determine the relative contribution of the transaldolase pathway
and the SBPase pathway, we generated a strain deﬁcient in
transaldolase activity (Supplementary Fig. 6a,b), and repeated the
formaldehyde assay. If Ru5P regeneration was mediated primarily
by increased entry into the PPP through transaldolase upon IA
treatment and glpX overexpression, then elimination of transal-
dolase should counteract the effect of these treatments on
reducing [CH2O]. By contrast, if Ru5P regeneration was mediated
by the SBPase pathway, deletion of transaldolase should have no
impact on formaldehyde assimilation. The results are shown in
Fig. 5d. As before, without the combination of IA treatment and
glpX overexpression, steady-state formaldehyde levels were
around 55 μM. In the glpX+ IA treatment, [CH2O] dropped to
18 ± 5 μM, a 2.5 ± 0.7-fold reduction which is comparable to that
seen in the transaldolase-positive strain (Fig. 5d). The [S7P] also
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showed the same patterns as with the parent strain (Supplemen-
tary Fig. 6c). These data support the conclusion that the improved
regeneration of Ru5P upon treatment with IA and overexpression
of glpX is mediated by activation of the SBPase RuMP pathway.
Assessing methanol dehydrogenase reversibility. Having
developed a strategy for achieving rapid consumption of for-
maldehyde without xylose supplementation, we sought to deter-
mine whether methanol oxidation was still thermodynamically
limited under these conditions, as this would inform subsequent
strategies to further improve methanol ﬂux. Comparing the
steady-state level of CH2O in strains expressing just Mdh to
strains harboring the full pathway allows calculation of an upper
limit for the ΔG, and thus the ratio of forward to reverse Mdh
ﬂux26 (Eq. 9), since the NAD:NADH ratio was the same in both
cases (Supplementary Fig. 7). This analysis is shown in Fig. 6a.
With no xylose supplementation, the small 1.2 ± 0.1-fold reduction
in [CH2O] achieved by expression of the full pathway (Fig. 3b)
means that only 55 ± 3% of the total ﬂux can be guaranteed to be in
the forward direction. With supplementation of xylose, a minimum
of 83 ± 5% of the ﬂux is in the forward direction, and with IA
treatment coupled with glpX overexpression, 75 ± 2% of the ﬂux is
forward. This analysis suggests that, with a strategy to ensure suf-
ﬁcient Ru5P regeneration, the pathway is not limited by the ther-
modynamics of the Mdh reaction.
These calculations assume that there is no spatial variation of
[CH2O]. However, there is evidence that [CH2O] is higher in the
immediate vicinity of the Mdh than in the bulk: in a recent study,
co-localizing Mdh with Hps led to signiﬁcant improved ﬂux
through the pathway18. We therefore sought an experiment to
directly determine to what extent the Mdh reaction was
thermodynamically limited. We reasoned that, if the formalde-
hyde concentration was close to equilibrium, improvements to
Mdh activity would result in only small changes in the overall
ﬂux, whereas if the reaction was kinetically limited, these changes
would manifest as large changes in methanol assimilation ﬂux.
This reasoning was conﬁrmed by dynamic simulations (Fig. 6b).
An initial attempt at varying Mdh activity by changing the level of
IPTG induction was unsuccessful. Poor Mdh solubility led
changes in [IPTG] to cause additional changes in growth and
substrate consumption rate, which confounds the assessment of
methanol ﬂux and Ru5P availability (Supplementary Fig. 8).
Instead, we reasoned that we could use deuterated methanol
(CD3OD) as a chemical modulator of Mdh activity, taking
advantage of the kinetic isotope effect (KIE) associated with
CD3OD oxidation to speciﬁcally lower-Mdh activity in vivo
without genetic intervention and the accompanying off-target
effects. If cells treated with 13CD3OD metabolized methanol more
slowly than the same cells treated with 13CH3OH, as assessed by
isotopic analysis of F6P, this would indicate the pathway was
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kinetically limited by Mdh. Further, the extent to which the
measured steady-state [CD2O] was lower than the [CH2O] for the
same cells could be quantitatively related to the reversibility of the
Mdh-catalyzed reaction (Eq. (24)).
To implement this approach, we ﬁrst veriﬁed the existence of a
KIE for Mdh. Assays with puriﬁed Mdh at physiological
conditions showed a roughly threefold decrease in activity
between CH3OH and CD3OD across a wide range of substrate
concentrations, and a kH/kD of 3.2 ± 1.3 (Fig. 6c). Importantly,
this KIE is signiﬁcantly higher than the typical equilibrium
isotope effect (EIE) for NAD-dependent primary alcohol
oxidations (1.07)27, and the secondary KIE expected for the
Hps-catalyzed aldol reaction (1.04)28, such that the impact of
CD3OD treatment on methanol ﬂux is predominantly realized
through the effect on Mdh kinetics.
Repeating the in vivo formaldehyde assay with cells expressing
only Mdh showed a 2.3 ± 0.3-fold decrease in initial formalde-
hyde production rate with CD3OD compared to CH3OH (Fig. 6d),
verifying the in vivo utility of CD3OD as a chemical probe of Mdh
kinetics. Notably, the steady-state concentration of [CH2O] and
[CD2O] under these conditions were almost identical, conﬁrming
the maximum [CH2O] in vivo is constrained by equilibrium.
We next repeated the assays with cells expressing the full
pathway under three conditions: (a) no supplementation, (b) glpX
overexpression with IA treatment, and (c) xylose supplementa-
tion. With no supplementation, the [CH2O]:[CD2O] ratio was
1.5 ± 0.3 (Fig. 6d), suggesting a limited impact of Mdh activity on
pathway ﬂux and highlighting the thermodynamic limitation,
with an estimated 56% of the Mdh ﬂux in the forward direction
(Fig. 6e). By contrast, in the glpX-IA treatment, the [CH2O]:
[CD2O] was 3.2 ± 0.4 (Fig. 6d), almost identical to the kH/kD,
indicating that the Mdh ﬂux was almost entirely in the forward
direction (Fig. 6e).
These results are consistent with the thermodynamic calcula-
tions in Fig. 6b, and are qualitatively consistent with the isotopic
analysis of F6P (Supplementary Fig. 9). In unsupplemented cells,
the unlabeled (M+ 0) fraction increased by a factor of 1.14 with
13CD3OD compared to 13CH3OH. In the glpX-IA treatment and
xylose treatment, this factor rose to 1.33 and 1.39, respectively
(Fig. 6e). In the xylose case, where formaldehyde concentrations
were too low to accurately determine the [CH2O]:[CD2O] ratio,
the similarity in the fractional M+ 0 F6P increase to the glpX-IA
case suggests methanol ﬂux is also kinetically limited under these
conditions (Fig. 6e). Taken together, these data demonstrate that,
under conditions of sufﬁcient [Ru5P], methanol assimilation ﬂux
is controlled by the activity of the Mdh enzyme.
Discussion
In this work, we showed that in order for methanol oxidation to
be forward driven, the steady-state formaldehyde concentration
must remain exceptionally low (<50 μM). In carbon-starved cells,
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depletion of PPP intermediates results in insufﬁcient [Ru5P] to
drive the assimilation of formaldehyde, regardless of the high
activity of Hps. Under these conditions, thermodynamic calcu-
lations and experiments with deuterated methanol conﬁrmed that
Mdh ﬂux is thermodynamically limited by proximity to equili-
brium. Inhibiting glycolysis by treatment with IA, coupled with
overexpression of glpX, activated the SBPase RuMP pathway and
led to a fourfold increase in [Ru5P] and a corresponding threefold
decrease in [CH2O] and twofold improvement in the incor-
poration of 13CH3OH. This resulted in forward-driven, kineti-
cally limited Mdh ﬂux, as demonstrated by the steady-state ratio
of [CH2O]:[CD2O] in cells treated with CH3OH or CD3OD.
Beyond establishing Mdh as forward-driven, the KIE experi-
ment revealed that, under conditions of sufﬁcient Ru5P regen-
eration, Mdh activity limits methanol ﬂux, even though the
evolved C. necator Mdh variant used in this study is the most
active variant known17,29. This suggests that future efforts to
improve methanol assimilation should focus on improving Mdh
kinetics. This could be achieved through expression optimization,
directed evolution, or through bioprospecting for more active
candidates. Critically, our analysis reveals that kinetically
improved Mdh variants will only enable improved methanol
oxidation rates in cells where formaldehyde assimilation is suf-
ﬁciently fast. This has important practical implications for the
development of Mdh-directed evolution approaches.
Interestingly, the co-metabolism of xylose reduced initial Mdh
velocity in vivo, and it was further shown that typical cellular
levels of NADH inhibit Mdh by ~50%. This potentially explains
why the strategy of methanol–glucose co-metabolism in Cor-
ynebacterium glutamicum16, and methanol–yeast extract co-
metabolism in E. coli13, resulted in low rates of methanol
assimilation. Genetic strategies for reducing [NADH] should
therefore be explored to further enhance Mdh kinetics30, as well
developing Mdh variants that are less sensitive to NADH.
Additionally, the strategy employed for Ru5P regeneration must
maintain a low [NADH] in order to drive methanol oxidation.
In a recent paper, Price et al. achieved impressive rates of
methanol consumption by co-localizing Mdh3 from Bacillus
methanolicus with the Hps from Mycobacterium gastrii, arguing
that the co-localization strategy was required to overcome the
reversibility of Mdh18. The results presented here challenge this
interpretation, as they demonstrate that [Ru5P] is the critical
factor in ensuring irreversible Mdh ﬂux. We suggest that the
success of the co-localization strategy may instead be due to the
very high formaldehyde Km of the M. gastrii Hps (2.96 mM31,
versus 147 μM for the B. methanolicus enzyme32), which requires
a high [CH2O] for signiﬁcant activity. Increased local con-
centration is a hallmark of enzyme co-localization33.
The strategy developed in this work to activate the SBPase
RuMP pathway is clearly not suitable to establish a methylo-
trophic E. coli strain, as it relies on a toxic inhibitor, and
expression of glpX leads to a futile cycle between F6P and FBP
that wastes cellular energy. However, the success of this approach
suggests GAPDH as a target for further metabolic engineering to
improve methanol assimilation, and identiﬁes the SBPase variant
of the RuMP pathway as the preferred cycle for Ru5P regenera-
tion. The requirement for reduced relative ﬂux into lower gly-
colysis is in agreement with theoretical predictions about the
stability of autocatalytic cycles such as the RuMP pathway,
wherein at low concentrations of the intermediate metabolite
(here Ru5P), the activity of the branching enzyme (GAPDH)
must be lower than that of the autocatalytic enzyme (Hps)34. It is
also consistent with a recent study where E. coli was evolved to
produce sugar from CO2, and where the only conserved mutation
was in the enzyme that serves as the main branchpoint out of the
autocatalytic Calvin cycle35. That both IA and glpX were required
for Ru5P regeneration suggests two possible mechanisms behind
the improvement: IA treatment dramatically increased [G3P],
and glpX increased [S7P]. Together, this increases the driving
force for and/or the rate of the transketolase reaction that
replenishes R5P and Xu5P (ΔG0′=+3.8 kJ mol−1), which are
converted to Ru5P. In the former case, there is a tradeoff between
additional ATP cost of the SBPase pathway, and the additional
driving force for Ru5P regeneration provided by its hydrolysis. In
the latter case, similar improvements may be seen by using a
transketolase variant with lower Km values. To avoid the F6P-FBP
futile cycle, an SBPase with lower afﬁnity for FBP could be
employed.
KIEs have been widely used in the interrogation of enzyme
mechanism36, but their use in probing metabolic pathways
remains limited37,38. To our knowledge, KIEs have not previously
been used to explore limitations in an engineered pathway. Here
we established a quantitative framework that leveraged KIEs to
discriminate between kinetic and thermodynamic control of the
Mdh reaction. The speciﬁcity of this tool was especially useful in
this context, where typical genetic methods for manipulating
Mdh activity caused secondary effects on growth rate that con-
founded the measurement and interpretation of methanol
assimilation ﬂux. This technique will be useful in future work on
methanol metabolism in E. coli, and could in principle be
extended to address limitations in other engineered pathways
containing enzymes with sufﬁcient KIEs, especially when genetic
intervention proves impractical.
More generally, the chemical biology techniques used in this
work (KIEs and chemical inhibition) represent useful but
underutilized tools in metabolic engineering39,40. GAPDH is an
essential enzyme in E. coli. Knocking it out requires deletion of
both isoforms and supplementation with multiple substrates41,
and downregulating its activity requires an elaborate genetic
strategy42. The use of a chemical inhibitor bypasses these
requirements, speeding up the process of identifying rate-limiting
steps, which then informs the design of genetically engineered
strains to achieve the same phenotype. This strategy is com-
plementary to the emerging strategy of designing and testing
novel metabolic pathways in vitro before encoding them geneti-
cally43–45. Given the success of these strategies, we therefore
believe that a continued close association between the ﬁelds of
chemical biology and metabolic engineering will enhance our
ability to rationally engineer strains in support of the goals of
sustainable chemical production46,47.
Methods
Reagents. Unless speciﬁed, all chemical reagents were purchased in the highest
grade available from Sigma. DIFCO M9 salts and LB, BACTO Agar, and casamino
acids were purchased from BD. Methanol-free formaldehyde (16% v/v) was pur-
chased as 1 mL ampules from ThermoFisher (Catalog #28906), and dilutions for
cellular assays were prepared fresh each day. Trace Elements (MD-TMS) and
Vitamin Solution (MD-VS) were purchased from ATCC. Isotopically labeled
substrates were purchased in the highest grade available from Cambridge Isotope
Laboratories.
Cell culture. LB was used in cloning and for growing cells for protein puriﬁcation.
For all other studies, cells were grown in M9+medium (DIFCO M9 amended with
1% MD-TMS and MD-VS) as follows: three colonies were inoculated from fresh
transformation plates into M9+medium supplemented with the desired carbon
source, 0.1% casamino acids, and the relevant antibiotics (kanamycin, 50 μg mL−1;
chloramphenicol, 25 μg mL−1) and grown overnight. Chloramphenicol stocks were
prepared in DMSO to avoid addition of Mdh substrates ethanol or isopropanol to
the media. In the morning, fresh M9+medium containing xylose or glycerol and
antibiotics was inoculated at 1–2% (v/v) from the overnight cultures, grown at 37 °
C, and then treated as described below for the relevant assays.
Cloning. All strains and plasmids generated in this study are listed in Supple-
mentary Table 3 Heterologous genes were codon-optimized for E. coli and
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synthesized as gBlock fragments by IDT (Supplementary Note 2). All plasmids
were assembled via Gibson assembly using primers shown in Supplementary
Table 4.
E. coli DNA fragments were ampliﬁed using Q5 Polymerase (NEB) and 0.5 μL
culture as a template in a 30 μL reaction. Gene deletions (frmA, talB, and zwf) were
generated using the CRISPR-Cas9 method described by Jiang et al.48, with the
modiﬁcation of curing the pCas9 plasmid at 42 °C. The pTarget vectors were
constructed in two steps: First, Gibson assembly was used to insert ~500 bp
homology regions upstream and downstream of the target gene into pTargetF
digested with XhoI. The homology regions were designed to make the exact
deletion described in the KEIO collection49. Next, the N20 region for the speciﬁc
gene (Supplementary Table 5) was incorporated by amplifying the vector
containing the homology region with a forward primer containing this sequence
(xxx-sg-F) and a common reverse primer (pTarget-sg-R), and assembling the linear
fragment after DpnI digest and puriﬁcation.
In generating a fully transaldolase-deﬁcient strain, the talA gene was not
removed completely, to minimize the risk of polar effects on expression of the
primary transketolase (tktB) from the same operon. Instead, a mutation was made
to the codon encoding the active site lysine50 (K131) using primers listed in
Supplementary Table 4. The point mutation was conﬁrmed by sequencing of the
PCR-ampliﬁed chromosomal fragment after curing of all cloning plasmids, and
transaldolase activity was assessed in crude lysates as described below.
In vivo formaldehyde timecourse assays. In vivo formaldehyde experiments
were performed essentially as described by Müller et al.12. Brieﬂy, cells were grown
in in M9+medium with xylose (6 g L−1) until early exponential phase (OD600
~0.5), and induced with 0.1 mM IPTG. After 2 h, cells were collected by cen-
trifugation at room temperature, washed once with M9+medium with no carbon
source, and resuspended again in carbon-free M9+medium to an OD600 of ~1.
Various substrates were then added as described in the text, and cells were incu-
bated for further 15 min at 37 °C before the addition of 250 mM labeled
(13CH3OH, CD3OD, or 13CD3OD) or unlabeled methanol. Cells were then sam-
pled periodically for internal metabolites, and supernatants were analyzed for
formaldehyde, as described below.
Formaldehyde analysis. Formaldehyde concentration in supernatants was assayed
by the Nash reaction51 modiﬁed for 96-well plate format. Aliquot of 200 μL cells
were spun down for 1 min at 16,000 × g, before transferring 125 μL supernatant to a
well. The plate was kept on ice until all samples had been collected. Aliquot of 125
μL Nash reagent (5 M NH4OAc, 50 mM acetylacetone) was added to each well, the
plate was incubated at 37 °C for 1 h, and absorbance was read on a SpectraMax
M2e spectrophotometer (Molecular Devices) at 412 nm. A standard curve was
prepared fresh daily in the range from 100 to 0 μM.
Intracellular metabolite extraction and quantiﬁcation. Intracellular metabolites
were extracted and isotope labeling patterns analyzed as described in ref. 52. Brieﬂy,
1–2 mL of liquid culture was ﬁltered through a 0.45 μm nylon ﬁlter, washed with
10 mL room temperature water, and then the ﬁlter was transferred into a 50 mL
falcon tube containing 5 mL of extraction solution (40:40:20 acetonitrile:methanol:
water) at −20 °C. After 30 min, the ﬁlter was removed, the samples were cen-
trifuged, and the supernatants dried overnight under air. The next morning, dried
metabolites were resuspended in 150 μL water, centrifuged at 16,000 × g for 20 min,
and injected into the LC-MS. Labeling distributions were corrected for natural
abundance using the software IsoCor53. For quantiﬁcation of internal metabolites,
the extraction solution was spiked with 13C internal standards that were previously
generated by growing E. coli on U−13C-labeled glucose (99%, Cambridge Isotope
Labs), and area of unlabeled peaks was normalized to the area of fully labeled peak,
as described in ref. 19.
Flux balance analysis. FBA simulations were carried out in MATLAB 2016b with
the CobraToolbox (v 2.0) and the Gurobi optimization package, using the core E.
coli model iAF126054, amended with the heterologous reactions catalyzed by Mdh,
Hps, and Phi, and their associated metabolites. Methanol uptake was assumed to be
mediated by passive diffusion. To compare ﬂux maps across different substrates,
growth was ﬁrst simulated with 10 mmol gDCW−1 h−1 glucose, and a growth rate
of 0.86 h−1 was determined. For growth on methanol, the substrate uptake rate was
varied until the growth rate was within 2% of the glucose growth rate, resulting in a
rate of 42 mmol gDCW−1 h−1 methanol.
Large-scale His-tag protein puriﬁcation. BL21(DE3) cells containing expression
plasmids with N-terminal 6-HIS fusions of mdh and glpX were grown overnight in
LB medium, then subcultured at 1% (v/v) into LB medium in bafﬂed ﬂasks, and
grown to early exponential phase (OD ~0.5). Expression was induced with IPTG at
0.1 mM, and growth continued for 3–5 h. Cultures were centrifuged, pellets taken
up in ice-cold extraction buffer (50 mM Tris-HCl (pH 7.5), 25 UmL−1 benzonase
(Sigma), 0.1 mM PMSF), and lysed by three passages through a high pressure
homogenizer (EmulsiFlex-C5). The soluble fraction was separated by centrifuga-
tion at 20,000 × g for 20 min at 4 °C. HIS-tagged proteins were puriﬁed using Ni-
NTA His-Bind Resin (EMD Millipore #70666) following the manufacturer’s
instructions. Imidazole was removed and protein concentrated by ﬁve passages
through a 3K MWCO Microsep centrifugal ﬁlter (Pall Laboratory #MCP003C41)
with ice-cold Tris-HCl (20 mM, pH 7.5).
SBPase assay. SBPase activity was determined qualitatively by following the
conversion of SBP to S7P by LC-MS/MS in the presence of puriﬁed GlpX. Since
SBP is not commercially available, it was prepared in situ using puriﬁed fructose
bisphosphate aldolase (FbaA), DHAP, and E4P. The assay mixture contained Tris-
HCl (50 mM, pH 7.5), 1 mM each substrate, and was initiated by addition of
enzyme. Products were analyzed after 1 h at 37 °C by LC-MS/MS according to the
method above after 100-fold dilution in H2O.
Methanol dehydrogenase assay. Methanol dehydrogenase activity was measured
by following the methanol-dependent reduction of NAD+ at 340 nm in 200 µL
ﬁnal volume using a clear, ﬂat-bottom 96-well plate and SpectraMax model M2e
plate reader with SoftMax Pro 6.5 software. For analysis of crude lysates, the assay
consisted of 100 mM glycine-KOH (pH 9.5), 5 mM MgSO4, and 1 mM NAD, and
was initiated by the addition of methanol. For analysis of puriﬁed enzyme to
establish KIE under physiologically relevant conditions55, the assays consisted of
25 mM K-phosphate (pH 7.5), 10 mM Na-glutamate, 5 mM MgSO4, 1 µM CaCl2,
150 mM KCl, 2.6 mM NAD+, and variable [MeOH] (6, 12, 35, 70, 150, and 300
mM) and were initiated by addition of enzyme (6.3 µM, ﬁnal concentration).
Product formation at 37 °C was quantiﬁed in comparison to a NADH standard
curve. Enzyme concentration was determined by UV absorbance at 280 nm in 6M
guanidine-HCl, 25 mM Na-phosphate (pH= 6.5); ε= 22,055M−1 cm−1.
Transaldolase assay. Transaldolase activity was determined qualitatively by fol-
lowing the conversion of F6P and E4P to S7P and G3P by LC-MS/MS in the
presence of crude lysates of various strains. EDTA (10 mM) was added 10 min
prior to starting the assay to inhibit transketolase activity. The assay mixture
contained Tris-HCl (50 mM, pH 7.5), 1 mM each substrate, and was initiated by
addition of enzyme. Products were analyzed after 1 h at 37 °C by LC-MS/MS
according to the method above after 100-fold dilution in H2O.
Methanol dehydrogenase expression analysis. For small-scale analysis of Mdh
expression in crude lysates, 1 mL of cell culture (OD600 ~ 0.5–1) was spun down (5
min, 16,000 × g), and the supernatant removed by aspiration. Pellets were frozen,
and then lysed with 100 μL BPER-Complete at room temperature for 15 min. The
soluble and insoluble fraction were separated by centrifugation at 20,000 × g for 10
min at 4 °C.
To estimate the amount of Mdh in the soluble and insoluble fraction, ﬁrst the
amount of Mdh in each fraction was calculated by image analysis after SDS-PAGE.
Aliquot of 10 μL of the soluble fraction was mixed with Laemmli buffer (BioRad).
The insoluble fraction was resuspended by vigorous pipetting in 100 μL BPER, and
10 μL mixed with Laemmli buffer. Samples were boiled for 5 min in a thermocycler,
before being run on a Mini-PROTEAN TGX gel (12%, 15-well comb, BioRad) at
150 V for ~1 h. Bands were visualized with InstantBlue gel stain (Expedeon) and
size was compared to BioRad Kaleidoscope pre-stained standards. Bands were
identiﬁed and quantiﬁed using the software AlphaImager HP. To quantify the total
amount of protein in the soluble and insoluble fraction, ﬁrst the insoluble fraction
was re-solubilized using 8 M guanidinium hydrochloride (Gu-HCl), and then
diluted threefold in water to reduce the Gu-HCl concentration. Protein
concentration was then determined by BCA Assay (Pierce). The amount of soluble
Mdh was then calculated as:
%MDHs ¼
MDH½ s
MDH½ sþ MDH½ i
¼ Protein½ sð%Proteins;MDHÞ
Protein½ s %Proteins;MDH
 
þ Protein½ ið%Proteini;MDHÞ
ð1Þ
where the subscripts s and i represent soluble and insoluble, respectively.
Derivation of equation for determining bounds on Mdh ΔG. Calculating a
precise value of ΔG requires an accurate value of ΔG0, and for the intracellular
concentrations of all the reactants and products. We can reasonably assume that
formaldehyde diffuses freely across the membrane, given that its appearance in the
supernatant can be measured shortly after its production begins intracellularly.
However, it is unlikely that the methanol concentration in the supernatant is the
same as that intracellularly—at 250 mM, methanol would be 2.5-fold more con-
centrated than glutamate, the metabolite with highest measured concentration in E.
coli19. To avoid the uncertainty in ΔG0 and methanol concentration in the cal-
culation, we use the differences in the concentrations of the relevant measurable
metabolites between cells expressing only Mdh, and cells expressing the full
pathway, treated in exactly the same way, to determine ΔG as follows:
ΔG1 ¼ ΔG0 þ RTlnQ1 andΔG2 ¼ ΔG0 þ RTlnQ2 ð2Þ
where the subscript 1 refers to Mdh-only, and subscript 2 refers to the full pathway.
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Assuming that the system is at equilibrium in the Mdh-only case, then
ΔG1 ¼ 0, ΔG0 ¼ RTlnQ1, and
ΔG2 ¼ RTlnQ1 þ RTlnQ2 ¼ RTln
Q2
Q1
 
ð3Þ
Since the methanol concentration is the same for both cases:
ΔG2 ¼ RTln
NADH½ 
NAD½ 
 
2
CH2O½ 2
NADH½ 
NAD½ 
 
1
CH2O½ 1
2
64
3
75 ð4Þ
If the NAD/NADH ratio is the same in both cases (discussed in the text), this
reduces to
ΔG2 ¼ RTln
CH2O½ 2
CH2O½ 1
 
ð5Þ
In reality, the system is likely not precisely at equilibrium with MDH-only,
given the reactivity of formaldehyde, such that ΔG1  0. Propagating this change
through the analysis leads to
ΔG2  RTln
CH2O½ 2
CH2O½ 1
 
ð6Þ
Thus, by measuring the difference in concentration of formaldehyde, and the
NAD/NADH ratio with and without Hps and Phi, we can place an upper bound on
ΔG2. The relationship between ΔG and the ratio of forward/reverse ﬂux (J
+/J−) has
been previously derived56, and is
ΔG ¼ RTln J
þ
J
 
ð7Þ
Therefore,
ΔG2 ¼ RTln
Jþ
J
 
 RTln CH2O½ 2
CH2O½ 1
 
ð8Þ
and
Jþ
J
 
 CH2O½ 1
CH2O½ 2
ð9Þ
Derivation of equation for KIE analysis. A mass balance on formaldehyde (F)
using mass action kinetics for each enzymatic step provides
d F½ 
dt
¼ k1 NAD½  CH3OH½   k1 NADH½  F½   k2 Ru5P½  F½  ð10Þ
Where k1 and k−1 denote the forward and reverse rate constants for Mdh, and k2
represents the irreversible forward rate constant of Hps. Solving for the steady-state
concentration of formaldehyde:
F½ SS¼
k1 NAD½  CH3OH½ 
k1 NADH½  þ k2 Ru5P½ 
ð11Þ
Denoting all parameters for protonated methanol and deuterated methanol
with “H” and “D” subscripts, respectively, and taking the ratio of steady-state
formaldehyde concentrations:
RH
D
¼ F½ SSH
F½ SSD
¼ k1H NAD½ H CH3OH½ H
k1H NADH½ Hþk2H Ru5P½ H
 k1D NADH½ Dþk2D Ru5P½ D
k1H NAD½ D CH3OH½ D
ð12Þ
Assuming the concentration of methanol, NAD+ and Ru5P to be equal in both
situations:
RH
D
¼ F½ SSH
F½ SSD
¼ k1H
k1H NADH½ Hþk2H Ru5P½ H
 k1D NADH½ Hþk2D Ru5P½ H
k1D
ð13Þ
Denoting the Mdh kinetic isotope effect (KIE) k1H/k1D as α, and assuming the
secondary isotope effect associated with Hps to be negligible:
RH
D
¼ F½ SSH
F½ SSD
¼ α k1D NADH½ Hþk2H Ru5P½ H
k1H NADH½ Hþk2H Ru5P½ H
 
ð14Þ
Denoting the ratio of Hps ﬂux to reverse Mdh ﬂux as
β ¼ k2H Ru5P½ H
k1H NADH½ H
ð15Þ
and substituting yields
RH
D
¼ F½ SSH
F½ SSD
¼ α k1D NADH½ Hþk1H NADH½ Hβ
k1H NADH½ H 1þ βð Þ
 
ð16Þ
Assuming [NADH] to be the same in both situations,
RH
D
¼ F½ SSH
F½ SSD
¼ α k1D þ k1Hβ
k1H 1þ βð Þ
 
ð17Þ
The equilibrium isotope effect (EIE), denoted γ is deﬁned as
γ ¼ k1Hk1H
 
= k1D
k1D
 
¼ α k1D
k1H
 
ð18Þ
Solving for k−1D yields
k1D ¼
γk1H
α
ð19Þ
Substituting into equation the expression for RH/D yields
RH
D
¼ F½ SSH
F½ SSD
¼ α
γk1H
α þ k1Hβ
k1H 1þ βð Þ
 !
ð20Þ
Simplifying yields
RH
D
¼ F½ SSH
F½ SSD
¼ γþ αβ
1þ β ð21Þ
Rearranging to solve for β, the ratio of Hps ﬂux to reverse Mdh ﬂux, as a
function of the measured formaldehyde ratios with protonated and deuterated
methanol, provides
β ¼
γ RH
D
RH
D
 α ð22Þ
which is used to calculate the reversibility of Mdh at steady state,
MDHF
MDHR
¼ 1þ β ¼ γ α
RH
D
 α ð23Þ
Solving for the Mdh forward ﬂux as a fraction of the total yields
MDHF
MDHF þMDHR
¼ 1þ β
2þ β ¼
γ α
γþ RH
D
 2α ð24Þ
Dynamic simulations of formaldehyde concentration. The ODE describing
formaldehyde production and consumption in the engineered pathway (Eq. (5))
was integrated by numerical integration in Microsoft Excel, using the kinetic
parameters in Supplementary Table 6, and a time step of 0.002 (arbitrary units).
The full data set is presented in Supplementary Data 1.
Statistical methods. Sample sizes were chosen based on precedent in the ﬁeld, and
no replicates were excluded from analysis. All error bars represent standard
deviations calculated from the number of replicates used in the particular experi-
ment, as indicated in the ﬁgures. Bounds on calculated ratios were derived from
error propagation from the mean and standard deviation of measurements.
Michaelis–Menten parameters and their conﬁdence intervals were calculated using
the MATLAB functions nlinﬁt() and nlparci(), respectively. Experiments were
neither blind nor randomized.
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Code availability. The MATLAB code used for calculating Michaelis–Menten
parameters is provided as Supplementary Note 3. The Excel ﬁle used for dynamic
formaldehyde simulations is provided as Supplementary Data 1.
Data availability. All data and materials that support the ﬁndings of this study are
available from the corresponding author on reasonable request.
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